Nonmalignant portal vein thrombosis affects 11% of cirrhosis patients over five years. Learn about the role of anticoagulants, endovascular interventions, and more in our latest clinical practice update. buff.ly/3EHmz9E

#GIsky

@drjessicadavis.bsky.social

🚨 1st output from @AST_LICOP #obesity & #livertransplant conf!

➡️ anti-obesity meds & surg. underutilized

➡️ #incretins promising pre- & post-txp

➡️ #AOM & #bariatric surg. complementary, not either/or

#liversky #GIsky

journals.lww.com/lt/abstract/99…

jamanetwork.com/journals/jam...

👀Can't-miss review of ♀️leadership in academia

🤯numbers:

▶️#medstudents 55% ♀️ , faculty 45% ♀️, chairs 25%♀️

▶️#obgyn residents 85% ♀️, #obgyn chairs 29% ♀️

A practical review of new AGA guidance on PVT management by @drjessicadavis.bsky.social
#liversky
📍don’t delay AC
📍can hold AC for EGD for 48 hours
📍AC does NOT increase risk of bleeding from varices while you wait for EGD

@atoosarabiee.bsky.social reviewing peri-op mgmt of #cirrhosis at #AHNGI&LiverSummit2025

🔹Use VOCAL-Penn for pre-op risk stratification

🔹Pre-surgical #TIPS in CSPH not ready for prime time

🔹🚫 prophylactic transfusion prior to surgery

#liversky #GIsky

Post liver biopsy bleeding risk:
Myth or fact?

A fun little project with my sis @anahitarabiee.bsky.social

#liversky

journals.lww.com/lt/fulltext/...

Check out our practical approach to PVT in cirrhosis 👀

@astinfo.bsky.social member spotlight: 💫 Dr. Ersilia DeFilippis, Transplant Cardiologist 🫀

"As an intern, I cared for a woman my age waiting for #hearttransplant. I was amazed by how transplant could transform someone's trajectory. I knew then that I wanted to go into transplant cardiology."

🤔 Which patients with #PVT should get AC?

🤔Do you band first?

🤔What is data behind DOAC for PVT?

🚨🚨AGA Clinical Practice Update on PVT Mgmt

www.gastrojournal.org/article/S001...

pragmatic review for busy GI with helpful algorithm 👀⬇️

#liversky #gisky #medsky

Cc @atoosarabiee.bsky.social @drjessicadavis.bsky.social

www.bbc.com/news/article...

Nice to see Debbie Shawcross (not on here yet!), @drgautammehta.bsky.social and others really highlighting this issue on various BBC platforms today!

#LiverSky
@adhanda.bsky.social
@aleksanderkrag.bsky.social

1/3 What happens when science and every day clinical practice comes together?

A 🧵

You get a packed room with not even a place to stand 👇🏼

Why?

I firmly believe that we need to bridge the gap between research and clinical application in our scientific meetings.

#TLM24

Packed house at Women’s luncheon for inspiring talk by past #AASLD president Dr. Teresa Wright, great way to close out my time at #TLM2024 💪💪🤸‍♀️

Yes, Achilles heel of this study is that so many things associated with not being on GLP are also associated with poor health outcomes so hard to give credit to drug for outcomes

We are proud of our small but mighty program — new DC VA transplant center:

⬆️ access

⬇️ wait times

🎯 maintained quality

#TLM2024 #TARGETNASH
impact of GLP-1 on clinical outcomes in #cirrhosis

non-GLP-users:
⬆️ decomp HR 1.69
⬆️ mortality HR 2.28

💪 large, real world, clinical

➡️ lingering questions:

- role of muscle mass changes & outcomes in GLP users?

- is lack of GLP a marker for lack of access?

#liversky

Great pHTN session at #TLM2024 ➡️ statin, AC, & anti-fibrotics are promising
➡️ carvedilol for all
➡️ preemptive #TIPS is life-saving with NNT 4️⃣‼️

#TLM2024 #liversky #portalhypertension
@atoosarabiee.bsky.social

First post 😊

I started my Twitter account in 2019 @aasld meeting, so it’s only fitting to restart this account for #TLM24 with my #liverbuddy
@drjessicadavis #liversky
Here we go!

Would love to be part of starter pack, thank you!